T argeted temperature management (TTM) may improve functional outcomes of patients with hypoxic ischemic encephalopathy after cardiac arrest and is recommended for these patients after the return of spontaneous circulation (ROSC) (1) . Sedative and analgesic infusions and neuromuscular blockade (NMB) agents are commonly used during TTM for comfort, suppression of shivering, and reduction of metabolic activity, but the optimal regimens are unknown, and dosing strategies vary widely (2) (3) (4) (5) . During TTM, shivering increases the systemic metabolic rate (6) , reduces brain oxygen levels (7), increases intracranial pressure (8) , and cause variability in body temperature, each of which can worsen secondary neurologic injury. To counteract these effects, different strategies have been proposed, ranging from high dose of sedatives and analgesics without NMB to much lower dose with intermittent or continuous NMB (2, 9, 10) .
Deeper sedation is associated with worse outcomes in other medical and surgical ICU populations (8, (11) (12) (13) (14) (15) . During TTM, observational studies suggest that sedatives and analgesics accumulate due to impaired metabolism, which can delay wakening, confound neurologic assessment, and potentially result in inappropriate withdrawal of life support (4, 9, (16) (17) (18) . Deeper sedation also may induce more hypotension with or without lower cardiac index, which may also affect outcomes (19) (20) (21) (22) . The approach to NMB during TTM also varies widely, from recommendations to avoid its use to observational data that continuous use may improve outcome after cardiac arrest (2, 4, 9, 10, (23) (24) (25) . For these reasons, optimization of sedation is thought to be essential in the management of patients with critical illness (26) , and the specific effects of sedation on cardiac arrest survivors undergoing TTM could be profound but are unknown.
Current literature available to address this issue has used single-center data to associate NMB dosing to outcome; however, it has likely not appropriately adjusted for underlying severity of illness and is complicated by patients with very severe brain injury having less shivering. The only randomized trial comparing continuous versus as-needed NMB dosing protocolized the as-needed group to escalating doses of sedation as well, making the results difficult to interpret. To address these controversies and inconsistencies, we evaluated sedation and shivering management practices in the International Cardiac Arrest Registry (INTCAR), a multicenter registry of patients that have been successfully resuscitated after in-hospital and out-of-hospital cardiac arrests.
MATERIALS AND METHODS

Centers and Patients
We included centers participating in the INTCAR registry between 2006 and 2017. The INTCAR registry consists of two iterations: a 1.0 dataset between the years of 2006 and 2011 and a 2.0 dataset between the years of 2011 and 2017. The core common variables of this retrospective data set were merged for this analysis. Centers enrolled consecutive adult patients admitted to an ICU after in-hospital or out-of-hospital cardiac arrest. Only patients treated with TTM were included, and management varied according to local best practices. The database was maintained at Lund, Sweden. Centers participated in the registry on a volunteer basis, and there was no reimbursement for enrolling patients, and all had institutional review board approval at their center. The merging of the 1.0 and 2.0 iteration and the analysis below were competed in R software version 1.0.136 (27) .
Sedation and Shivering Practices
Patient-level sedation data were not part of the INTCAR database. Center-specific sedation and shivering practices (SPs) were assessed using a Research Electronic Data Capture-based survey hosted at Tufts University (28) . Surveys were sent by e-mail to the investigators listed in the INTCAR system up to three times, on different days of the week. Centers that did not respond were then contacted directly by the administrators of INTCAR and asked to complete the survey. Two investigators independently assigned centers into one of the three categories based on their survey results: SP1 indicated escalating sedation dosing and avoidance of NMB, SP2 indicated sedation with either scheduled or continuous NMB to prevent shivering, and SP3 indicated sedation with as-needed NMB in response to shivering. Only centers that enrolled at least 20 patients and completed the survey were included in the analysis.
Outcome
The primary outcome was Cerebral Performance Category (CPC) at 6 months as a dichotomous variable, with good outcome defined as CPC of 1 or 2 and poor outcome as CPC of 3-5. Secondary outcome was CPC at ICU discharge. The 6-month CPC outcome was assessed with a review of medical records or telephone call to the patient or their proxy.
Predictors
Candidate variables included in both INTCAR iterations were age, sex, number of prior medical conditions (coronary artery disease, congestive heart failure, arrhythmia, chronic obstructive pulmonary disease, hypertension, chronic kidney disease, neurologic disease, liver disease, malignancy, obesity, insulindependent diabetes mellitus, and noninsulin-dependent diabetes mellitus), ischemic time, location of arrest (in hospital vs out of hospital), rhythm (shockable, nonshockable, and unknown), bystander cardiopulmonary resuscitation (CPR), witnessed CPR, number of beds at each center, and country of center (European vs United States). These were extracted by chart review at the individual centers and uploaded into the Lytics server. Continuous variables were tested for linearity assumptions.
Missing Data
Missing data were assessed, and those with variables with greater than 10% missing data were estimated with multiple imputation. The imputation method was predictive mean metric, where five coefficients are assigned for each missing data point based on closest matches with complete data, and then, samples of the donors are randomly selected, and the observed value is returned. This was repeated 10 times
Statistical Analysis Methods
Predictors were separated into patient-level and center-level sets. To account for shared variance between center, sedation use, and patient use, a hierarchical model was used with two levels (patients at level 1 and centers at level 2) with SP as a fixed effect at center level. Explanatory variables were largely treated as dichotomous for yes/no variables, and continuous variables were assessed for linearity with the logit of the outcome variables. Age was grouped by decade, and ROSC was grouped by 5-minute intervals. Past medical history consisted of a sum of relevant prearrest diagnoses listed above. Candidate variables were assessed in a univariate manner using logistic regression, and variables were retained in the model if the p value was less than 0.20. The decision was made a priori to force certain selected variables into the model, regardless of significance based on clinical importance (ROSC, rhythm, location, bystander CPR).
RESULTS
Survey
Thirty-five eligible INTCAR centers were sent surveys, and 20 (57%) responded. Each center was assigned to one of the three categories based on their survey results without discrepancy between the assigners.
Patient Population
A total of 4,267 patients at 20 centers were included in the dataset. The mean age was 62 (± 15) years, 34% (n = 1,432) were female, and 77% (n = 3,256) were out-of-hospital arrests. There were similar rates of shockable and nonshockable rhythms, and mean ischemic time was 24 (± 18) minutes. Further characteristics, including characteristics from the complete INTCAR dataset,are described in Table 1 . At 6-month follow-up 1,349 (32%) had a good outcome, with similar results at ICU discharge (1,313 [31%] ).
Missing Data
At least one variable was missing from 23% of patients. Eleven percent of patients had more than one variable of missing data. The most common variable with missing data was bystander CPR. Multiple imputation was performed with five imputations and pooled for the final analysis. (2) 10 (1) 15 (1) 39 (2) Time to return of spontaneous circulation, mean (sd) 24 (18) 24 (18) 23 (18) 26 (22) 22 (15) Bystander cardiopulmonary resuscitation, n (%) development, a priori interactions were tested and not found to be significant. All univariate variables were found to be significant and were retained in the model. First, the global p value for sedation level for each outcome was tested, followed by testing the three SPs referenced to SP 1.
Model Development
Model Specification
The full model is shown in Supplemental (Fig. 2) .
DISCUSSION
In patients receiving TTM after cardiac arrest, improved functional outcomes was associated with patients admitted to centers that used as-needed NMB with an adjunctive sedation regimen compared with centers using escalating sedation dosing and limiting NMB, including after adjustment for major confounders. This is the largest study to evaluate the impact of sedation and NMB on outcomes after cardiac arrest. Current guidelines recommend "light" sedation (i.e., awake and responsive) in the general ICU population, which is associated with improved outcomes (13, 30) , but applying this approach to cardiac arrest patients undergoing TTM is inappropriate. Monitoring the depth of sedation has not been validated in brain-injured patients, as mental status changes may be secondary to brain injury rather than sedation.
In addition to inconsistent sedation strategies during TTM, the use of NMB varies widely, and the benefits or risks are uncertain. A recent guideline for the use of NMB in the ICU made no recommendation regarding the use of NMB during TTM (31) . Several observational TTM studies have concluded that NMB administration was associated with improved outcome (23) (24) (25) although these studies did not robustly adjust for underlying severity of illness. Some experts have recommended avoiding NMB during TTM (1, 10) . Shivering itself is associated with good outcome after cardiac arrest (32) possibly because the most severely injured brains do not mount a shivering response. Therefore, requiring treatment for shivering with NMB may reflect a less severe brain injury and thus explain the association with better outcome. The most recent study was a single-center study of 63 randomized continuous Critical Care Medicine www.ccmjournal.org e979 versus as-needed NMB. This study's positive finding was fewer shivering episodes in the continuous NMB group. Secondary outcomes showed lower doses of sedatives and analgesics, decreased length of ICU stay, and earlier awakening in the continuous NMB group. However, it is important to note that patients received escalating doses of sedatives and analgesics with each dose of rocuronium per protocol (33) . Therefore, it is unclear if the time to awakening and ICU stay is reflective of the NMB practice or the protocol of increasing sedation and analgesia in the as-needed NMB group. Our analysis, where sedation and shivering strategies were defined at the hospital level, avoids this within-patient confounder and may be more generalizable to a center-treatment approach.
Worse outcomes associated with escalating sedation dosing sedation after cardiac arrest has several plausible explanations. The metabolism of many sedatives and analgesics decreases during hypothermia (16, 34, 35) likely resulting in accumulation of medication, which can confound neuroprognostication after cooling, resulting in inappropriate withdrawal of life support. Targeting a moderate depth of sedation and using NMB to treat shivering reduce the overall dose of sedatives, particularly for those who shiver vigorously and appears to reduce the time to wakening after TTM (4, 36) . Higher doses of sedation to control shivering without NMB may also reduce blood pressure, known to influence outcome in animal cardiac arrest models (37, 38) and retrospective human studies (20, 39) . In addition, escalating doses of sedation without NMB may incompletely control shivering, increase variability in body temperature, or delay adequate suppression of shivering. Excess shivering has the potential to delay time to target temperature, elevate intracranial pressure, and lower brain oxygen levels. Sedation also has immunology effects (40, 41) , which may increase the rate of infection, time on the ventilator, and prolong ICU course (2, 13) . Last, improved outcome with asneeded doses of NMB may be a reflection of increased bedside monitoring of patients.
Although this is the largest study to evaluate the effects of sedation on outcomes after cardiac arrest, several limitations warrant discussion. The INTCAR data were collected prospectively, but sedation and NMB doses were not collected at the patient level. However, every center had a sedation protocol, and although between-patient variability occurs within each center, centers with established protocols may have less drastically divergent variations in treatment sufficient to confound these results. Also centers who choose to participate in INTCAR have a particular interest in postresuscitation care, and it is unclear how these results apply to other centers. Next, the effect of similar sedation approaches within each center may not be consistent across all patients. It is also possible that these effects on outcome may be due to variation in sedation protocols or from other unmeasured differences in practice, such as increased bedside attentiveness with as-needed NMB protocols. Also, it should be noted that the groups were not comparable for several variables known to influence outcomes after cardiac arrest; however, we used the preferred statistical method of hierarchal logistic regression to minimize bias between these groups. Also, it is possible that the SP could have changed significantly over the course of the study. The survey attempted to address this, asking if and how practices changed after the year 2012 (start of INTCAR 2.0). Fifty percent of centers reported a significant change in their protocol; however, citing reasons would not have altered their SP category (i.e., changing from fentanyl to remifentanyl or inclusion of dexmedetomidine). There were two centers that responded that there was a significant change in their protocol but did not explain what that was. One of these centers included patients in both 1.0 and 2.0 datasets, and 170 patients were in the 1.0 dataset and could have been inappropriately assigned.
Protocols for sedation and shivering management of patients undergoing TTM are variable (TTM), and the only randomized trial to address this is difficult to interpret differences in NMB dosing or sedation dosing as an influence to outcome. Our data suggest that good outcome is associated with the use of a protocol that favors as-needed NMB with basal sedation instead of increasing sedation to avoid NMB in response to shivering after cardiac arrest. Prospective study evaluating sedative and NMB use at the patient level, with outcomes adjusted for severity of illness, is warranted.
